Peripheral blood proteome biomarkers distinguish immunosuppressive features of cancer progression

Peripheral blood proteome biomarkers distinguish immunosuppressive features of cancer progression

Immune status critically affects cancer progression and therapy responses. This study aimed to identify plasma proteome changes in immunosuppressive cancer and potential biomarkers predicting systemic immunosuppression. Mouse models of syngeneic breast tumors (benign 67NR and malignant 4T1) were use...

Full description

Saved in:
Bibliographic Details
Main Authors: Yeon Ji Park, Jae Won Oh, Hyewon Chung, Jung Won Kwon, Yi Rang Na, Kwang Pyo Kim, Seung Hyeok Seok
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Molecular Oncology
Subjects:
biomarker
immunosuppressive cancer
myeloid‐derived suppressor cells
plasma
proteomics
Online Access:https://doi.org/10.1002/1878-0261.13817
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/1878-0261.13817

Similar Items